|
There are other more specific agents for HCV being developed - however, it
will likely be at least 2-3 years before they become appropriate for
clinical practice - thus for some patients with more advanced disease who
have failed treatment we have tried to examine other strategies, such as
lowdose PEGinterferon. You may wish to consider this with your doctor. We
can expect, however, that once the new treatments arrive, we will be in a
much better position to treat pts who had problems with therapy or who were
nonresponders.
|
|